[2010-2021 年 357 家全科医生诊所和 71 家专科诊所的阿尔茨海默氏症痴呆症和抗痴呆症药物处方]。

IF 1.1 4区医学 Q4 PSYCHIATRY

Psychiatrische Praxis Pub Date : 2024-10-09 DOI:10.1055/a-2370-1933

Jens Bohlken, Karel Kostev, Bernhard Michalowsky

{"title":"[2010-2021 年 357 家全科医生诊所和 71 家专科诊所的阿尔茨海默氏症痴呆症和抗痴呆症药物处方]。","authors":"Jens Bohlken, Karel Kostev, Bernhard Michalowsky","doi":"10.1055/a-2370-1933","DOIUrl":null,"url":null,"abstract":"Background: The predicted prevalence of people with dementia (PWD) in Germany has risen to 1.8 million since 2010. In the near future, we will see the approval of antibody therapies. The study aims to demonstrate the recent anti-dementia medication prescriptions and diagnosis prevalence.Methods: Data from 357 general practitioner (GP) and 71 specialist practices (SP) (1.1 Mio. patients) were analyzed to demonstrate the prevalence of dementia diagnoses and anti-dementia drug prescriptions between 2010 and 2021.Results: The diagnosis prevalence of PWD (Alzheimer's dementia) remained relatively constant in GP practices at 1.0-1.3% (0.19-0.21%). Among SP, the prevalence increased from 4.9% (2.8%) to 5.9% (3.6%). The anti-dementia prescription rate decreased in GP (from 0.14% to 0.10%) and increased in SP practices (from 2.1% to 2.4%).Discussion: The diagnosis and prescription rate, especially in GP practices, remained below the prevalence forecasts and the expected prescriptions.","PeriodicalId":20711,"journal":{"name":"Psychiatrische Praxis","volume":" ","pages":""},"PeriodicalIF":1.1000,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Alzheimer's Dementia and Anti-Dementia Medication Prescriptions 2010-2021 in 357 GP Practices and 71 Specialist Practices].\",\"authors\":\"Jens Bohlken, Karel Kostev, Bernhard Michalowsky\",\"doi\":\"10.1055/a-2370-1933\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Background: The predicted prevalence of people with dementia (PWD) in Germany has risen to 1.8 million since 2010. In the near future, we will see the approval of antibody therapies. The study aims to demonstrate the recent anti-dementia medication prescriptions and diagnosis prevalence.Methods: Data from 357 general practitioner (GP) and 71 specialist practices (SP) (1.1 Mio. patients) were analyzed to demonstrate the prevalence of dementia diagnoses and anti-dementia drug prescriptions between 2010 and 2021.Results: The diagnosis prevalence of PWD (Alzheimer's dementia) remained relatively constant in GP practices at 1.0-1.3% (0.19-0.21%). Among SP, the prevalence increased from 4.9% (2.8%) to 5.9% (3.6%). The anti-dementia prescription rate decreased in GP (from 0.14% to 0.10%) and increased in SP practices (from 2.1% to 2.4%).Discussion: The diagnosis and prescription rate, especially in GP practices, remained below the prevalence forecasts and the expected prescriptions.\",\"PeriodicalId\":20711,\"journal\":{\"name\":\"Psychiatrische Praxis\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.1000,\"publicationDate\":\"2024-10-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Psychiatrische Praxis\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1055/a-2370-1933\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychiatrische Praxis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2370-1933","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PSYCHIATRY","Score":null,"Total":0}

引用次数: 0

摘要

背景：自 2010 年以来，德国痴呆症患者（PWD）的预测患病率已上升至 180 万。在不久的将来，我们将看到抗体疗法获得批准。本研究旨在展示最近的抗痴呆药物处方和诊断流行率：分析了 357 名全科医生（GP）和 71 名专科医生（SP）（110 万患者）的数据，以展示 2010 年至 2021 年间痴呆症诊断和抗痴呆症药物处方的流行情况：结果：在全科医生诊所中，残疾人（阿尔茨海默氏痴呆症）的诊断率相对稳定在 1.0-1.3% (0.19-0.21%)。在 SP 中，患病率从 4.9%（2.8%）上升到 5.9%（3.6%）。全科医生的抗痴呆处方率有所下降（从0.14%降至0.10%），而专科医生的处方率有所上升（从2.1%升至2.4%）：讨论：诊断率和处方率，尤其是全科医生的诊断率和处方率，仍然低于患病率预测值和预期处方率。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

[Alzheimer's Dementia and Anti-Dementia Medication Prescriptions 2010-2021 in 357 GP Practices and 71 Specialist Practices].

Background: The predicted prevalence of people with dementia (PWD) in Germany has risen to 1.8 million since 2010. In the near future, we will see the approval of antibody therapies. The study aims to demonstrate the recent anti-dementia medication prescriptions and diagnosis prevalence.

Methods: Data from 357 general practitioner (GP) and 71 specialist practices (SP) (1.1 Mio. patients) were analyzed to demonstrate the prevalence of dementia diagnoses and anti-dementia drug prescriptions between 2010 and 2021.

Results: The diagnosis prevalence of PWD (Alzheimer's dementia) remained relatively constant in GP practices at 1.0-1.3% (0.19-0.21%). Among SP, the prevalence increased from 4.9% (2.8%) to 5.9% (3.6%). The anti-dementia prescription rate decreased in GP (from 0.14% to 0.10%) and increased in SP practices (from 2.1% to 2.4%).

Discussion: The diagnosis and prescription rate, especially in GP practices, remained below the prevalence forecasts and the expected prescriptions.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Psychiatrische Praxis PSYCHIATRY-

CiteScore

3.90

自引率

9.10%

发文量

103

期刊介绍： Sozialpsychiatrisch orientiert Aktuelle Originalarbeiten und fundierte Übersichten Pro-Kontra-Debatten zu Brennpunktthemen Informative Fallbeispiele Vorstellung internationaler Studien